137 related articles for article (PubMed ID: 15727558)
1. Application of sterylglucoside-containing particles for drug delivery.
Maitani Y; Nakamura K; Kawano K
Curr Pharm Biotechnol; 2005 Feb; 6(1):81-93. PubMed ID: 15727558
[TBL] [Abstract][Full Text] [Related]
2. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol].
Shi J; Yan WW; Qi XR; Yang L; Zhang L
Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849
[TBL] [Abstract][Full Text] [Related]
3. [Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
Shi J; Qi XR; Yang L; Fei R; Wei L
Yao Xue Xue Bao; 2006 Jan; 41(1):19-23. PubMed ID: 16683522
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
[TBL] [Abstract][Full Text] [Related]
5. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol.
Qi XR; Yan WW; Shi J
World J Gastroenterol; 2005 Aug; 11(32):4947-52. PubMed ID: 16124043
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
Muramatsu K; Maitani Y; Takayama K; Nagai T
Drug Dev Ind Pharm; 1999 Oct; 25(10):1099-105. PubMed ID: 10529890
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
8. Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture.
Shimizu K; Tamagawa K; Takahashi N; Takayama K; Maitani Y
Int J Pharm; 2003 Jun; 258(1-2):45-53. PubMed ID: 12753752
[TBL] [Abstract][Full Text] [Related]
9. The enhancing effect of soybean-derived sterylglucoside and beta-sitosterol beta-D-glucoside on nasal absorption in rabbits.
Maitani Y; Nakamura K; Suenaga H; Kamata K; Takayama K; Nagai T
Int J Pharm; 2000 Apr; 200(1):17-26. PubMed ID: 10845682
[TBL] [Abstract][Full Text] [Related]
10. Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.
Shimizu K; Maitani Y; Takayama K; Nagai T
Biol Pharm Bull; 1997 Aug; 20(8):881-6. PubMed ID: 9300135
[TBL] [Abstract][Full Text] [Related]
11. Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
Shimizu K; Qi XR; Maitani Y; Yoshii M; Kawano K; Takayama K; Nagai T
Biol Pharm Bull; 1998 Jul; 21(7):741-6. PubMed ID: 9703260
[TBL] [Abstract][Full Text] [Related]
12. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
Mainardes RM; Urban MC; Cinto PO; Chaud MV; Evangelista RC; GremiĆ£o MP
Curr Drug Deliv; 2006 Jul; 3(3):275-85. PubMed ID: 16848729
[TBL] [Abstract][Full Text] [Related]
13. Association of liposomes containing a soybean-derived sterylglucoside mixture with rat primary cultured hepatocytes.
Shimizu K; Maitani Y; Takahashi N; Takayama K; Nagai T
Biol Pharm Bull; 1998 Aug; 21(8):818-22. PubMed ID: 9743249
[TBL] [Abstract][Full Text] [Related]
14. [Physico-chemical characterization and application for drug carrier of soybean-derived sterols and their glucosides-containing liposomes].
Maitani Y
Yakugaku Zasshi; 1996 Dec; 116(12):901-10. PubMed ID: 8993229
[TBL] [Abstract][Full Text] [Related]
15. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled mirror DNA nanostructures for tumor-specific delivery of anticancer drugs.
Kim KR; Kim HY; Lee YD; Ha JS; Kang JH; Jeong H; Bang D; Ko YT; Kim S; Lee H; Ahn DR
J Control Release; 2016 Dec; 243():121-131. PubMed ID: 27746274
[TBL] [Abstract][Full Text] [Related]
17. [Nanostructured liposomal systems as transport agents for anticancer drugs].
Baryshnikov AIu
Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
[TBL] [Abstract][Full Text] [Related]
18. Effects on M5076-hepatic metastasis of retinoic acid and N-(4-hydroxyphenyl) retinamide, fenretinide entrapped in SG-liposomes.
Takahashi N; Tamagawa K; Shimizu K; Fukui T; Maitani Y
Biol Pharm Bull; 2003 Jul; 26(7):1060-3. PubMed ID: 12843642
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route.
Ding WX; Qi XR; Fu Q; Piao HS
Drug Deliv; 2007 Feb; 14(2):101-4. PubMed ID: 17364874
[TBL] [Abstract][Full Text] [Related]
20. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer.
Suga T; Fuchigami Y; Hagimori M; Kawakami S
Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]